BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12100750)

  • 1. Effects of various principles from Chinese herbal medicine on rhodamine123 accumulation in brain capillary endothelial cells.
    He L; Liu GQ
    Acta Pharmacol Sin; 2002 Jul; 23(7):591-6. PubMed ID: 12100750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of multidrug resistance reversal agents with P-glycoprotein ATPase activity on blood-brain barrier.
    He L; Liu GQ
    Acta Pharmacol Sin; 2002 May; 23(5):423-9. PubMed ID: 11978192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P glycoprotein regulated transport of glutamate at blood brain barrier.
    Liu XD; Liu GQ
    Acta Pharmacol Sin; 2001 Feb; 22(2):111-6. PubMed ID: 11741514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX; Yang XH
    Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of E6, a novel calmodulin inhibitor, on activity of P-glycoprotein in purified primary cultured rat brain microvessel endothelial cells.
    Zhu HJ; Liu GQ
    Acta Pharmacol Sin; 2003 Nov; 24(11):1143-9. PubMed ID: 14627500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of p-glycoprotein inhibitor combinations on drug efflux from rat brain microvessel endothelial cells.
    Yang ZY; Liu GQ
    Pharmazie; 2004 Dec; 59(12):952-6. PubMed ID: 15638085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
    Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
    J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.
    Tang XQ; Bi H; Feng JQ; Cao JG
    Acta Pharmacol Sin; 2005 Aug; 26(8):1009-16. PubMed ID: 16038636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-glycoprotein restricted transport of nimodipine across blood-brain barrier.
    Zhang L; Liu XD; Xie L; Wang GJ
    Acta Pharmacol Sin; 2003 Sep; 24(9):903-6. PubMed ID: 12956939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of P-glycoprotein function by procyanidine on blood-brain barrier.
    He L; Zhao C; Yan M; Zhang LY; Xia YZ
    Phytother Res; 2009 Jul; 23(7):933-7. PubMed ID: 19172664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance.
    Fu L; Liang Y; Deng L; Ding Y; Chen L; Ye Y; Yang X; Pan Q
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):349-56. PubMed ID: 14666379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
    Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
    J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine.
    Jin J; Wang FP; Wei H; Liu G
    Cancer Chemother Pharmacol; 2005 Feb; 55(2):179-88. PubMed ID: 15378274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CJZ3, a lomerizine derivative, modulates P-glycoprotein function in rat brain microvessel endothelial cells.
    Ji BS; He L; Li XQ; Liu GQ
    Acta Pharmacol Sin; 2006 Apr; 27(4):414-8. PubMed ID: 16539840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of drug efflux transport kinetics in various blood-brain barrier models.
    Bachmeier CJ; Trickler WJ; Miller DW
    Drug Metab Dispos; 2006 Jun; 34(6):998-1003. PubMed ID: 16554372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efflux transport of a new quinolone antibacterial agent, HSR-903, across the blood-brain barrier.
    Murata M; Tamai I; Kato H; Nagata O; Tsuji A
    J Pharmacol Exp Ther; 1999 Jul; 290(1):51-7. PubMed ID: 10381759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of P-glycoprotein function by amlodipine derivatives in brain microvessel endothelial cells of rats.
    Ji BS; He L; Liu GQ
    Acta Pharmacol Sin; 2005 Feb; 26(2):166-70. PubMed ID: 15663893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vivo and in-vitro studies on the effect of Huang-Lian-Jie-Du-Tang on nimodipine transport across rat blood-brain barrier.
    Zhang DM; He ZW; Liu XD; Li Y; Xie L; Wang GJ; Liu L
    J Pharm Pharmacol; 2007 Dec; 59(12):1733-8. PubMed ID: 18053337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased P-glycoprotein function and level after long-term exposure of four antiepileptic drugs to rat brain microvascular endothelial cells in vitro.
    Yang HW; Liu HY; Liu X; Zhang DM; Liu YC; Liu XD; Wang GJ; Xie L
    Neurosci Lett; 2008 Apr; 434(3):299-303. PubMed ID: 18313849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.